Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

According to a recent study published in JACC: Advances, researchers have discovered that certain blood markers typically ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

The project will leverage Noetik's AI model and multimodal spatial data to search for biomarkers of patient response to Agenus' immunotherapy regimen.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and Noetik, a leader in AI-driven spatial and multimodal biology, today announced a research collaboration to develop predictive ...

Rhythm Biosciences is focused on both detecting cancers early, as well as predicting an individual's chances of contracting the disease.

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Study reveals the advantages and pitfalls of adding a TKI to a monoclonal antibody after chemoradiation for non-small cell ...

Biomarker-targeted adjuvant therapy improved survival in early-stage NSCLC, highlighting the importance of testing and ...